2-Amino-2-methylpropan-1-ol
| Associated High Confidence AOPs |
|---|
No associated AOPs with Level of Relevance 1
Associated AOPs with Level of Relevance 2
| AOP Identifier | AOP Title | AO Classification | OECD Status | Coverage Score | KE Identifier | KE Name |
|---|---|---|---|---|---|---|
| AOP:38 | Protein Alkylation leading to Liver Fibrosis | Gastrointestinal System Disease | WPHA/WNT Endorsed | 0.14 | KE:344 | N/A, Liver fibrosis |
| AOP:144 | Endocytic lysosomal uptake leading to liver fibrosis | Gastrointestinal System Disease | Under Review | 0.11 | KE:344 | N/A, Liver fibrosis |
| AOP:383 | Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis | Gastrointestinal System Disease | Under Development | 0.17 | KE:344 | N/A, Liver fibrosis |
| AOP:463 | The AOP framwork on silica nanopariticles induced hepatoxicity | Gastrointestinal System Disease | - | 0.09 | KE:344 | N/A, Liver fibrosis |
| AOP:494 | AhR activation leading to liver fibrosis | Gastrointestinal System Disease | - | 0.17 | KE:344 | N/A, Liver fibrosis |
No associated AOPs with Level of Relevance 3
No associated AOPs with Level of Relevance 5
DISCLAIMER
TICToK is a database of tattoo ink chemicals compiled from different regulatory resources. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on tattoo ink chemicals is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.